TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Novo Genetix AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
972
|
423
|
408 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
50
|
-45
|
-38 |
| EBITDA |
50
|
-45
|
-38 |
| Total assets |
263
|
213
|
296 |
| Current assets |
263
|
213
|
296 |
| Current liabilities |
31
|
25
|
42 |
| Equity capital |
200
|
151
|
196 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
76.0%
|
70.9%
|
66.2% |
| Turnover per employee |
972
|
423
|
408 |
| Profit as a percentage of turnover |
5.1%
|
-10.6%
|
-9.3% |
| Return on assets (ROA) |
19.0%
|
-21.1%
|
-12.8% |
| Current ratio |
848.4%
|
852.0%
|
704.8% |
| Return on equity (ROE) |
25.0%
|
-29.8%
|
-19.4% |
| Change turnover |
549
|
15
|
-97 |
| Change turnover % |
130%
|
4%
|
-19% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.